ABBV Kronos AI forecast
A 30-trading-day price forecast for AbbVie Inc. (ABBV) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts AbbVie Inc. at $240.87 on 2026-12-08, −15.9% from the last close of $286.39 on 2026-10-27. Eight out of ten sampled paths end between $229.73 and $249.39, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of ABBV
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $286.23 | $279.87 | $291.83 |
| 2026-11-10 | $267.93 | $237.55 | $274.86 |
| 2026-11-17 | $248.29 | $228.22 | $254.71 |
| 2026-11-24 | $244.39 | $235.04 | $249.54 |
| 2026-12-01 | $241.01 | $229.12 | $244.74 |
| 2026-12-08 | $240.87 | $229.73 | $249.39 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for ABBV?
- Kronos AI's median forecast for ABBV is $240.87 in 30 trading days, −15.9% from the last close, with a 10–90% range of $229.73 to $249.39.
- Is the ABBV Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC
- ABT — Abbott Laboratories